Filter
447
Text search:
López,
L.
Featured
Recommendations
33
New Publications
70
Language
Document type
No document type
194
Studies & Reports
125
Guidelines
72
Manuals
26
Fact sheets
13
Strategic & Response Plan
8
Training Material
7
Situation Updates
1
Infographics
1
Countries / Regions
Global
22
Latin America and the Carribbean
19
Western and Central Europe
10
Russia
10
India
8
Eastern Europe and Central Asia
7
Venezuela
7
Philippines
6
Brazil
6
Kenya
5
Bangladesh
5
Colombia
5
Middle East and North Africa
5
Eastern Europe
5
Nigeria
4
Ethiopia
4
Germany
4
Syria
4
Tanzania
4
Malawi
4
Benin
4
South Africa
3
Mozambique
3
Ukraine
3
Angola
3
Yemen
3
South–East Asia Region
3
Africa
3
Mali
2
Cameroon
2
Uganda
2
Haiti
2
Nepal
2
South Sudan
2
Zambia
2
Cambodia
2
China
2
Indonesia
2
Peru
2
Myanmar / Burma
2
Vietnam
2
North America
2
Portugal
2
Spain
2
Burkina Faso
1
Sierra Leone
1
Senegal
1
USA
1
Ghana
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Rwanda
1
Malaysia
1
Argentina
1
Eswatini/ Swaziland
1
Ecuador
1
Bolivia
1
Madagascar
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Western Pacific Region
1
Paraguay
1
Asia
1
Estonia
1
Romania
1
Kyrgyzstan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
99
Clinical Guidelines
40
Women & Child Health
37
Public Health
23
Key Resources
14
Capacity Building
4
Pharmacy & Technologies
2
Toolboxes
Mental Health
60
COVID-19
59
TB
50
HIV
25
NTDs
25
Planetary Health
22
NCDs
21
Cholera
14
Rapid Response
9
Disability
8
Caregiver
7
AMR
6
Natural Hazards
5
Global Health Education
5
Pharmacy
5
Malaria
5
Ebola & Marburg
4
Refugee
4
Conflict
3
2.0 Rapid Response
3
Zika
2
Polio
1
Health Financing Toolbox
1
As of 6:00 PM, 21 November 2013, 4,011 individuals were reported dead, 18,567 injured and 1,602 are still missing
Guia Colombia
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur
...
Externalising disorders
Chapter D.3
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
The technical note by the Global Task Force on Cholera Control (GTFCC) discusses the use of Oral Cholera Vaccines (OCVs) for international workers and travelers in cholera-affected areas. It reviews the effectiveness of WHO-prequalified vaccines (Dukoral®, Shanchol™, and Euvichol®), emphasizing
...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The
...
PLoS Med. 2009 Oct;6(10):e1000159. doi: 10.1371/journal.pmed.1000159. Epub 2009 Oct 6.
PLoS ONE 11(1): e0144662. doi:10.1371/journal.pone.0144662
Perspectives on drugs
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i
...
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Menthol in tobacco products
El plan de estudios le ayudará a usted, y a su comunidad, a entender la ciencia del virus que causa el COVID-19 y otros virus similares. Le ayudará a descubrir cómo este virus le afecta o puede afectarle en el futuro. Le ayudará a comprender las medidas que puede tomar para mantenerse a salvo y
...